Danaher Co. (NYSE:DHR) is Cadinha & Co. LLC’s 7th Largest Position

Cadinha & Co. LLC boosted its stake in Danaher Co. (NYSE:DHR) by 15.2% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 219,070 shares of the conglomerate’s stock after buying an additional 28,970 shares during the quarter. Danaher makes up about 2.8% of Cadinha & Co. LLC’s investment portfolio, making the stock its 7th largest position. Cadinha & Co. LLC’s holdings in Danaher were worth $20,334,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently made changes to their positions in the company. Arthur M. Cohen & Associates LLC acquired a new position in Danaher in the fourth quarter worth $25,249,000. Advisor Partners LLC raised its position in shares of Danaher by 4.5% during the fourth quarter. Advisor Partners LLC now owns 13,312 shares of the conglomerate’s stock worth $1,339,000 after acquiring an additional 575 shares during the last quarter. K.J. Harrison & Partners Inc bought a new stake in shares of Danaher during the fourth quarter worth $928,000. FTB Advisors Inc. raised its position in shares of Danaher by 14.9% during the fourth quarter. FTB Advisors Inc. now owns 4,064 shares of the conglomerate’s stock worth $386,000 after acquiring an additional 528 shares during the last quarter. Finally, Robeco Institutional Asset Management B.V. raised its position in shares of Danaher by 23.2% during the fourth quarter. Robeco Institutional Asset Management B.V. now owns 102,029 shares of the conglomerate’s stock worth $9,471,000 after acquiring an additional 19,187 shares during the last quarter. 75.88% of the stock is currently owned by institutional investors and hedge funds.

In other news, EVP William K. Daniel sold 131,066 shares of the stock in a transaction that occurred on Friday, February 2nd. The stock was sold at an average price of $102.05, for a total transaction of $13,375,285.30. Following the transaction, the executive vice president now owns 270,523 shares in the company, valued at $27,606,872.15. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, SVP Daniel Raskas sold 37,870 shares of the firm’s stock in a transaction on Thursday, November 16th. The stock was sold at an average price of $93.33, for a total value of $3,534,407.10. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 274,913 shares of company stock valued at $27,729,293. Insiders own 12.20% of the company’s stock.

Danaher Co. (DHR) opened at $95.41 on Tuesday. Danaher Co. has a 52-week low of $78.97 and a 52-week high of $104.82. The company has a current ratio of 1.43, a quick ratio of 1.05 and a debt-to-equity ratio of 0.39. The company has a market capitalization of $66,370.00, a P/E ratio of 27.26, a P/E/G ratio of 1.99 and a beta of 1.04.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Tuesday, January 30th. The conglomerate reported $1.19 EPS for the quarter, beating the consensus estimate of $1.16 by $0.03. Danaher had a return on equity of 11.36% and a net margin of 13.60%. The firm had revenue of $5.09 billion during the quarter, compared to analysts’ expectations of $4.97 billion. During the same period in the prior year, the firm posted $1.05 earnings per share. The business’s quarterly revenue was up 10.9% compared to the same quarter last year. equities analysts predict that Danaher Co. will post 4.37 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which was paid on Friday, January 26th. Stockholders of record on Friday, December 29th were given a $0.14 dividend. The ex-dividend date of this dividend was Thursday, December 28th. This represents a $0.56 dividend on an annualized basis and a dividend yield of 0.59%. Danaher’s payout ratio is 16.00%.

A number of equities research analysts have recently weighed in on the company. Credit Suisse Group boosted their target price on Danaher from $99.00 to $105.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 31st. Zacks Investment Research downgraded Danaher from a “buy” rating to a “hold” rating in a report on Tuesday, December 19th. Stifel Nicolaus reiterated a “buy” rating and issued a $110.00 price objective on shares of Danaher in a report on Friday, January 19th. Robert W. Baird reiterated a “buy” rating on shares of Danaher in a report on Friday, January 12th. Finally, UBS Group initiated coverage on Danaher in a report on Monday, January 22nd. They issued a “buy” rating and a $99.97 price target for the company. One analyst has rated the stock with a sell rating, five have assigned a hold rating, fourteen have issued a buy rating and one has issued a strong buy rating to the company. The company has an average rating of “Buy” and an average target price of $100.13.

TRADEMARK VIOLATION NOTICE: “Danaher Co. (NYSE:DHR) is Cadinha & Co. LLC’s 7th Largest Position” was published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this piece on another domain, it was copied illegally and republished in violation of US and international trademark and copyright legislation. The legal version of this piece can be read at https://www.dispatchtribunal.com/2018/02/13/danaher-co-dhr-shares-bought-by-cadinha-co-llc.html.

About Danaher

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply